BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3150301)

  • 1. Management of non A, non B hepatitis: the problem and its treatment.
    Thomas HC; Jacyna MR; Main J
    Chemioterapia; 1988 Dec; 7 Suppl 3():30-4. PubMed ID: 3150301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast beta-interferon: a preliminary report.
    Ohnishi K; Nomura F; Iida S
    Am J Gastroenterol; 1989 Jun; 84(6):596-600. PubMed ID: 2499184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of acute and chronic viral hepatitis.
    Hoofnagle JH
    Adv Intern Med; 1994; 39():241-75. PubMed ID: 8140956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.
    Dienstag JL; Alter HJ
    Semin Liver Dis; 1986 Feb; 6(1):67-81. PubMed ID: 3012784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated hepatitis C virus (non-A, non-B) infection.
    Polesky HF; Hanson MR
    Arch Pathol Lab Med; 1989 Mar; 113(3):232-5. PubMed ID: 2493234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-A, non-B hepatitis: a contemporary assessment.
    Blum HE; Vyas GN
    Haematologia (Budap); 1982; 15(2):153-73. PubMed ID: 6819208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
    Poynard T; Leroy V; Cohard M; Thevenot T; Mathurin P; Opolon P; Zarski JP
    Hepatology; 1996 Oct; 24(4):778-89. PubMed ID: 8855176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transfusion etiology and non-cirrhotic histology improve the remission rate of chronic hepatitis C during interferon treatment.
    Halpern Z; Arber N; Hallak A; Konikoff F; Santo M; Moshkowitz M; Tomny E; Gilat T
    Isr J Med Sci; 1995 Jun; 31(6):341-4. PubMed ID: 7607851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monophasic and polyphasic pattern of alanine aminotransferase in acute non-A, non-B hepatitis. Clinical and prognostic implications.
    Pastore G; Monno L; Santantonio T; Angarano G; Trotta F; Schiraldi O
    Hepatogastroenterology; 1985 Aug; 32(4):155-8. PubMed ID: 3932172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term course of non-A, non-B post-transfusion hepatitis.
    Koretz RL; Stone O; Gitnick GL
    Gastroenterology; 1980 Nov; 79(5 Pt 1):893-8. PubMed ID: 6774906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-A, Non-B hepatitis : status of current knowledge (authors' transl)].
    Sohier R; Trepo C
    Rev Epidemiol Sante Publique; 1980 Oct; 28(3):341-66. PubMed ID: 6781019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-A, non-B viral hepatitis: occurrence, epidemiology and prognosis].
    Altorfer J; Roten A; Pirovino M; Bühler H; Frösner G; Schmid M
    Schweiz Med Wochenschr; 1981 May; 111(22):799-800. PubMed ID: 6787703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis non-A, non-B: epidemiological significance in acute viral hepatitis and chronic active hepatitis of hepatological consultation].
    Jmelnitzky AC; Basualdo JA; Belloni PO; Ponce de León HH; García C; Curciarello J
    Acta Gastroenterol Latinoam; 1987; 17(1):15-23. PubMed ID: 3126619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transfusion non-A, non-B hepatitis in Finland: a prospective study.
    Lagerstedt A; Leikola J; Merikallio E; Ukkonen P
    Scand J Clin Lab Invest; 1982 Nov; 42(7):567-70. PubMed ID: 6818679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for chronic viral hepatitis.
    Alvarez F
    Clin Invest Med; 1996 Oct; 19(5):381-8. PubMed ID: 8889278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of sporadic acute non-A, non-B hepatitis in Japan: a comparison with hepatitis A and B.
    Nagata A; Kiyosawa K; Koike Y; Miura M; Gibo Y; Sodeyama T; Wada S; Akahane Y; Furuta S
    Am J Gastroenterol; 1985 Apr; 80(4):298-302. PubMed ID: 3920901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non A, non B-hepatitis in children].
    Bosch C; Rotthauwe HW; Becker M
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):721-5. PubMed ID: 6815483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.